Cargando…

Exploratory analysis of circulating cytokines in patients with metastatic breast cancer treated with eribulin: the TRANSERI-GONO (Gruppo Oncologico del Nord Ovest) study

BACKGROUND: Anticancer drugs can interact with the tumour microenvironment and their effects could be exploited to favour anticancer immune response. Eribulin contributes to tumour vasculature remodelling and transforming growth factor β (TGF-β) modulation in experimental models and in humans. We pe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garrone, Ornella, Michelotti, Andrea, Paccagnella, Matteo, Montemurro, Filippo, Vandone, Anna Maria, Abbona, Andrea, Geuna, Elena, Vanella, Paola, De Angelis, Claudia, Lo Nigro, Cristiana, Falletta, Antonella, Crosetto, Nicola, Di Maio, Massimo, Merlano, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555105/ https://www.ncbi.nlm.nih.gov/pubmed/33051191 http://dx.doi.org/10.1136/esmoopen-2020-000876

Ejemplares similares

Randomised controlled trial comparing single agent paclitaxel vs epidoxorubicin plus paclitaxel in patients with advanced ovarian cancer in early progression after platinum-based chemotherapy: an Italian Collaborative Study from the ‘Mario Negri’ Institute, Milan, G.O.N.O. (Gruppo Oncologico Nord Ovest) group and I.O.R. (Istituto Oncologico Romagnolo) group
por: Buda, A, et al.
Publicado: (2004)

Circulating Cytokines in Metastatic Breast Cancer Patients Select Different Prognostic Groups and Patients Who Might Benefit from Treatment beyond Progression
por: Paccagnella, Matteo, et al.
Publicado: (2022)

Eribulin in pretreated metastatic breast cancer patients: results of the TROTTER trial—a multicenter retrospective study of eribulin in real life
por: Garrone, Ornella, et al.
Publicado: (2016)

Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer (ERIGE trial). Clinical and pharmacogenetic results on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC)
por: Pellegrino, B., et al.
Publicado: (2020)

Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: a multicentre randomised trial. Gruppo Oncologico Campano.
por: Comella, P., et al.
Publicado: (1996)

Cytokine Profiling of End Stage Cancer Patients Treated with Immunotherapy
por: Merlano, Marco Carlo, et al.
Publicado: (2021)

Circulating cytokines and outcome in metastatic colorectal cancer patients treated with regorafenib
por: Ricci, Vincenzo, et al.
Publicado: (2020)

Knowing the tumour microenvironment to optimise immunotherapy
por: MERLANO, M.C., et al.
Publicado: (2019)

How Chemotherapy Affects the Tumor Immune Microenvironment: A Narrative Review
por: Merlano, Marco Carlo, et al.
Publicado: (2022)

The Role of Cytokinome in the HNSCC Tumor Microenvironment: A Narrative Review and Our Experience
por: Denaro, Nerina, et al.
Publicado: (2022)

Activation of hypothalamic gono-like neurons in female rats during estrus☆
por: Ren, Xiaoxuan, et al.
Publicado: (2012)

Baseline Cytokine Profile Identifies a Favorable Outcome in a Subgroup of Colorectal Cancer Patients Treated with Regorafenib
por: Abbona, Andrea, et al.
Publicado: (2023)

Baseline Values of Circulating IL-6 and TGF-β Might Identify Patients with HNSCC Who Do Not Benefit from Nivolumab Treatment
por: Merlano, Marco Carlo, et al.
Publicado: (2023)

Prognostic and clinical impact of the endocrine resistance/sensitivity classification according to international consensus guidelines for advanced breast cancer: an individual patient-level analysis from the Mammella InterGruppo (MIG) and Gruppo Italiano Mammella (GIM) studies
por: Lambertini, Matteo, et al.
Publicado: (2023)

The search for a melanoma-tailored chemotherapy in the new era of personalized therapy: a phase II study of chemo-modulating temozolomide followed by fotemustine and a cooperative study of GOIM (Gruppo Oncologico Italia Meridionale)
por: Guida, Michele, et al.
Publicado: (2018)

Metronomic oral chemotherapy with cyclophosphamide plus capecitabine combined with trastuzumab (HEX) as first line therapy of HER-2 positive advanced breast cancer: A phase II trial of the Gruppo Oncologico Italia Meridionale (GOIM)
por: Orlando, Laura, et al.
Publicado: (2020)

Tratammiento alternativo en pacientes oncológicos : /
por: Larraga Bautista, Deisy Areli
Publicado: (2014)

V Meeting Nazionale Gruppo Italiano di Paleopatologia
Publicado: (2019)

Serie ósea metastásica en pacientes oncológicos
por: Bello Morales, Edgar
Publicado: (2016)

Manejo no farmacológico del dolor crónico no oncológico
por: Ruiz-Romero, M.V., et al.
Publicado: (2022)

Replacement of AA nord-10 by nord-100 compact
por: Chohan, V
Publicado: (1986)

Manejo del paciente canino oncológico : guía práctica para la atención compasiva /
por: Ogilvie, Gregory K.
Publicado: (2008)

Nord contre sud
por: Verne, Jules, 1828-1905
Publicado: (1935)

Prevalencia del estado nutricional en pacientes oncológicos pediátricos : /
por: Fernández Rosario, Karla
Publicado: (2015)

Atención tanatológica a pacientes oncológicos en fase terminal
por: Castro Morales, Citlalli Jahzzel
Publicado: (2009)

TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group
por: Cremolini, Chiara, et al.
Publicado: (2017)

Cuidados de enfermería en pacientes en estado crítico oncológico
por: Barrientos Pozos, Norma Leticia
Publicado: (1991)

La esperanza en el paciente oncológico: hacia una reconceptuación
por: Llantá Abreu, María del Carmen, et al.
Publicado: (2014)

PACIENTES ONCOLÓGICOS DIAGNOSTICADOS COM COVID-19 E SEUS PROGNÓSTICOS
por: Junior, M.A.S.
Publicado: (2020)

Dolor crónico no oncológico: dónde estamos y dónde queremos ir
por: García Espinosa, María Victoria, et al.
Publicado: (2018)

CERN : Retour du Nord
Publicado: (1985)

NORD-10 is powerful and impressive
por: CERN. Geneva
Publicado: (1979)

NORD-10 computer online
Publicado: (1974)

Online with a NORD-10
Publicado: (1974)

Eribulin drug review
por: Shetty, Nishitha, et al.
Publicado: (2014)

Eribulin in Cancer Treatment
por: Swami, Umang, et al.
Publicado: (2015)

Incidence of cetuximab-related infusion reaction in head and neck cancer patients: may we predict it?
por: Merlano, Marco C, et al.
Publicado: (2018)

Cotes-du-Nord : Richesses de France

Dose-dense adjuvant chemotherapy in early breast cancer patients: 15-year results of the Phase 3 Mammella InterGruppo (MIG)-1 study
por: Blondeaux, Eva, et al.
Publicado: (2020)

Treatments after progression to first-line FOLFOXIRI and bevacizumab in metastatic colorectal cancer: a pooled analysis of TRIBE and TRIBE2 studies by GONO
por: Rossini, Daniele, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_aa70quf26s5pnf70snsui0nke0